Mon, Jul 6, 2015
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 1.63% in December; Healthcare & Biotechnology Index up 13.79% in 2012 (+8.27% 2012)

Monday, January 14, 2013
Opalesque Industry Update: Hedge funds gained 1.63% in December, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index had positive returns in 10 out of 12 months in 2012, and was up 8.27% at year-end.

“Buoyant equity markets at the beginning of the month collided with fiscal cliff fears at mid-month, only to explode higher on December 31st,” says Sol Waksman, founder and president of BarclayHedge.

The Barclay Pacific Rim Equities Index was up 3.17% in December, Emerging Markets gained 2.87%, European Equities were up 2.24%, Equity Long Bias gained 2.04%, and Distressed Securities added 1.95%.

“Hedge fund returns outpaced the S&P 500 for a third consecutive month in December, but stilled lagged by 7.76 percent at year-end,” says Waksman.

Three of Barclay’s 18 hedge fund strategies lost ground in December. The Equity Short Bias Index dropped 5.97%, Technology lost 0.33%, and Equity Market Neutral slipped 0.06%.

The Healthcare & Biotechnology Index led all hedge fund strategies in 2012 with a 13.79% gain, Distressed Securities gained 12.05%, the European Equities Index was up 10.17%, Emerging Markets added 9.94%, Equity Long Bias was up 9.34%, and Fixed Income Arbitrage gained 9.33%.

“Now that the boomer generation has begun to swell the ranks of senior citizens and Obamacare is the law of the land, the outlook for healthcare and biotech appears to be bullish,” says Waksman.

The Equity Short Bias Index was the only losing hedge fund strategy in 2012, suffering a negative return of 24.18%. This is the biggest one-year loss for Equity Short Bias since BarclayHedge began tracking its performance in 1997. The previous record was a 23.95% loss in 2003.

The Barclay Fund of Funds Index gained 1.05% in December, and was up 4.60% in 2012.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Opalesque Exclusive: New systematic strategy managed alongside research firm outperforms S&P500[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: An emerging CTA manager explains how he runs his strategy, which is based on an index produced by a research firm. Peter Turk is head of

  2. Opalesque Exclusive: New systematic strategy embraces machine learning[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: The founder of a New York-based systematic trading firm, which offers a hybrid between alpha strategies and alternative feta at lower fees, describes his approa

  3. Larry Robbins' hedge fund Glenview buys 1m Tenet Healthcare shares[more]

    Komfie Manalo, Opalesque Asia: Glenview Capital Management said it bought an additional 979,482 shares at Tenet Healthcare Corp valued at $53.80 million, raising its stakes in the healthcare services company to 15.16%, reported

  4. Legal - Grayson’s hedge funds under scrutiny for possible ethics violations, Court rejects hedge fund’s motion to block merger of Samsung affiliates[more]

    Grayson’s hedge funds under scrutiny for possible ethics violations From Freebeacon.com: Rep. Alan Grayson is finding himself in hot water over managing hedge funds that bear his name, actions that are in possible violation of House ethics rules. Sitting members of Congress are prohibite

  5. Hedge funds decline in June as stocks tumble on Greek woes[more]

    From Bloomberg.com: Hedge funds posted losses across strategies last month as uncertainty over whether Greece will remain in the euro sent global stock markets tumbling. Winton Capital Management declined about 3.1 percent in June in its $12.1 billion Winton Futures Fund, leaving it down 1.9 percent

 

banner